AmerisourceBergen proudly announces its intent to change its name to Cencora to reflect its bold vision and purpose-driven approach to creating healthier futures. Read more: https://t.co/YubpIjuC1Z

Dennis Nelson, Director of Biosimilar Commercialization, spoke with @Citeline about how the biosimilars market is evolving, highlighting new launch strategies, private-label activity, and regulatory developments that may accelerate access. Read more: https://t.co/XqeElUa9lk

For @PharmaCommerce, Heather Zenk, President of U.S. Supply Chain at Cencora, shares how technology, collaboration, and smarter sourcing are just a few ways we’re defining Cencora’s role in more resilient, sustainable pharma supply chains. Read more: https://t.co/XH8c9EjEEt

Proactive CMC strategies are critical for CGT developers to avoid regulatory delays and bring therapies to patients faster. In @PharmaExec, Cencora experts Louis Cicchini, and Michael Day, share how developers can reduce the risk of FDA complete response letters:

IntrinsiQ Specialty Solutions is expanding its data and insights to support precision medicine, providing manufacturers with real-world visibility into therapy use. See how this strengthens connections across the healthcare ecosystem: https://t.co/ICJJjxWl5y

As of August 27, most distributors successfully met the enhanced tracing requirements under the Drug Supply Chain Security Act (DSCSA)—a major step forward in securing the pharmaceutical supply chain. Read more on Regulatory Focus: https://t.co/AkXrnuR1wu

Expanding access to healthcare starts with reducing barriers to treatment – especially for specialty medications. In @SpecialtyPharm, Chara Reid and Christie Smith point to approaches like medically integrated dispensing to improve coordination and patient access:

In her @PharmaCommerce video interview series, Heather Zenk, President of U.S. Supply Chain at Cencora, shares insights on building a more resilient and efficient pharmaceutical supply chain. Watch the full series here: https://t.co/VeYdC8p5fn

John Arena, President of Global Pharma Services, shares why accelerated regulatory pathways demand accelerated readiness—plus insights on payer engagement, global planning, and commercialization strategy on In Vivo Citeline. Learn more: https://t.co/1ygo5xEalB

Cell and gene therapy breakthroughs require a well-planned path to market. Cencora VP Kevin Chinn shares why early and integrated planning is key to avoiding regulatory, access, and logistics hurdles in @PharmaCommerce: https://t.co/Xv9U3XlW1g

Since the first approved gene therapy in the field six years ago, cell and gene therapy studies in ophthalmology may offer hope for untreatable conditions. Cencora’s Louis Cicchini, PhD, breaks down the progress, promise, and potential for @ModernRetina: https://t.co/bdtGYPbaDi

MWI Animal Health is investing in the leaders of tomorrow, today. See how initiatives like the Future Leaders program are cultivating confident, cross-functional leaders who help the entire organization thrive in @Vet_Advantage: https://t.co/xLfoAHRH9i

In @ChainDrugReview, Cencora leaders Heather Zenk and Rich Tremonte share how we're using innovation to help prevent supply disruptions while enabling our customers to deliver essential therapies with greater speed and reliability: https://t.co/PvKoG91SLM

Our best solutions start by listening to our customers’ most pressing challenges. For @ChainDrugReview, Jay Dombi & @GoodNeighborRx’s Jenni Zilka share how Cencora Marketplace was built collaboratively to help pharmacies meet evolving community needs: https://t.co/locSzEVK1O

What’s needed to bring innovative pharmaceuticals to market? Cencora SVP Sandra Anderson joins Alloga and ICS SVP Chris Williams on @pharmaphorum to discuss what smaller biotech companies need to ensure a successful go-to-market strategy: https://t.co/Nc0fSZ8RqO

Good Neighbor Pharmacy is harnessing data to help independent pharmacies uncover and close care gaps. 📊 Jenni Zilka and Cencora’s Tim Cernohous break it down in Chain Drug Review. Flip for the full story: https://t.co/uCHQssqGf7

At Cencora’s TMF Leadership Summit, the balance of oversight in outsourced trials took center stage. Watch why Rob Jones, product manager, Pharmalex says “trust but verify” is key for collaborative and compliant outcomes for @Clin_Trials: https://t.co/FxS4BgmejV

Brent Wilhelm, SVP of Supply Chain Planning & Optimization, spoke with Pharmaceutical Executive about the critical role of a resilient supply chain and the benefits of a centralized entry model, smart monitoring tech, and steps to mitigate disruptions: https://t.co/lnqIbq5RUV

Claire Biermaas recently shared insights with Drug Store News on the retail pharmacy industry's shift towards value-based, patient-centered care models and how technology can streamline processes to enhance experiences for both patients and pharmacists. https://t.co/0FsNLpdCve

Michael Culme-Seymour, Regional Vice President for Asia Pacific (APAC) for World Courier sits down with BioSpectrum Asia to discuss the latest trends in pharma logistics and how Cencora is positioned to address these emerging challenges. Read it here: https://t.co/u2w0vrB11w

Healthcare providers and pharmaceutical companies alike rely on our work as distributors to provide patients with access to the medication they need. Read more to find out what might happen in a world without distributors: https://t.co/udIBc0taUX